Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine

June 10, 2024

Medically reviewed by
By Ernie Mundell HealthDay Reporter

An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.

The shot — for now called mRNA-1083 — “has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial,” Moderna said.

The dual-purpose shot, won’t be okayed in time for this years’ flu season.

Read more…


Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail Clients: Contact your Client Relations Manager